Berkeley Lights Stock
Cell Manipulation for Personalized Therapies
Sign up today and learn more about Berkeley Lights Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Berkeley Lights Stock
Berkeley Lights, Inc. (BLI) is a platform for single cell manipulation that allows for researchers to analyze cells. It aims to provide platforms that automate the manipulation and analysis of cells. The Beacon platform, the company's flagship product, is suited for cell line development, antibody discovery, gene editing, and antibody engineering workflows. The platform uses optofluidics and light-based technology to automate the work of cloning, culturing and sorting specific cells from biological samples. By automating these processes, they aim to cut the time and human labor needed to develop cell lines, discover and engineer antibodies, and do gene editing.
On June 26, 2020, Berkeley Lights filed to go public. Click here to see Berkeley Light's IPO paperwork.
The company was founded in 2011 in Emeryville, California.
Investors
AJS Investments
Atinum Investment
Black Diamond Ventures
Cota Capital
Zymergen, Gusto, Berkeley Lights, Eight Sleep, OpenGov, Bonobos, Movandi, Bossa Nova Robotics, inDinero
KTB Network
Paxion Capital Partners
Innovium, H2O.ai, Berkeley Lights, Bossa Nova Robotics, Katerra
Sequoia Capital
Market Kurly, Robinhood, Airbnb, Instacart, Tokopedia, Stripe, DoorDash, Rappi, CoinSwitch Kuber, UiPath
Shangbay Capital
Varian
Walden Riverwood Ventures
Funding History
| August 2011 | $183K |
|---|---|
| April 2012 | $500K |
| August 2012 | $4.0M |
| July 2014 | $29.2M |
| April 2015 | $58.6M |
| November 2016 | $40.0M |
| June 2018 | $95.0M |
Management
Chief Executive Officer
Eric Hobbs
Chief Financial Officer
Shaun Holt
Chief Scientific Officer
Kevin Chapman, Ph.D.
Chief Technology Officer
Keith Breinlinger, Ph.D.
Vice President, People Operations
Sheri Kelleher
SVP, Marketing
John Proctor, Ph.D.
General Counsel
Stuart Merkadeau
SVP, Global Sales
Mark Lasinski
Press
nanalyze - Jul, 5 2020
All About the Berkeley Lights Stock IPOGlobeNewswire - May, 12 2020
Abveris Announces Human Antibody Discovery Partnership with Nkarta using the Trianni Mouse® on the Berkeley Lights Beacon®PR Newswire - Apr, 27 2020
Berkeley Lights Launches Two New Capabilities in the Opto Cell Therapy Development 1.0 Workflow to Accelerate the Creation Of Effective Cancer Immunotherapies TSan Francisco Business Times - Mar, 13 2020
How the coronavirus validated Berkeley Lights' technology and its supply chainPR Newswire - Mar, 9 2020
Berkeley Lights Launches Cell Line Development 2.0 Workflow to Find Top Clones for Complex Antibody TherapeuticsPR Newswire - Feb, 28 2020
Researchers Worldwide Are Using Berkeley Lights' Beacon Platform To Combat COVID-19PR Newswire - Jan, 2 2020
Berkeley Lights Launches Culture Station to Increase Capacity of its Beacon® and Lightning™ Optofluidic Platformsfiercebiotech - Oct, 1 2019
Ginkgo forms $150M cell screening pact with Berkeley Lightssynbiobeta - Sep, 16 2019
The growth and bottlenecks of synthetic biology: say hello to Berkeley Lightsfinance - Sep, 5 2019
Berkeley Lights Opens Shanghai Locationprnewswire - Aug, 7 2019
Berkeley Lights Names Sarah Boyce To Board of Directorsprnewswire - Jun, 10 2019
Berkeley Lights, Inc. And Amyris Announce Collaboration To Speed Testing Of Microbial Strainsbioportfolio - May, 18 2019
ChemPartner Adds B Cell Discovery from Berkeley Lights to OfferingsEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
